Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 97 to 99 of 99 entries
Sorted by: Best Match Show Resources per page
Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.

Journal of cancer research and clinical oncology

Öcal O, Schütte K, Kupčinskas J, Morkunas E, Jurkeviciute G, de Toni EN, Ben Khaled N, Berg T, Malfertheiner P, Klümpen HJ, Sengel C, Basu B, Valle JW, Benckert J, Gasbarrini A, Palmer D, Seidensticker R, Wildgruber M, Sangro B, Pech M, Ricke J, Seidensticker M.
PMID: 33855585
J Cancer Res Clin Oncol. 2021 Apr 14; doi: 10.1007/s00432-021-03627-1. Epub 2021 Apr 14.

PURPOSE: To explore the potential correlation between baseline interleukin (IL) values and overall survival or objective response in patients with hepatocellular carcinoma (HCC) receiving sorafenib.METHODS: A subset of patients with HCC undergoing sorafenib monotherapy within a prospective multicenter phase...

Cite
Öcal O, Schütte K, Kupčinskas J, et al. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial. J Cancer Res Clin Oncol. 2021;doi: 10.1007/s00432-021-03627-1.
Öcal, O., Schütte, K., Kupčinskas, J., Morkunas, E., Jurkeviciute, G., de Toni, E. N., Ben Khaled, N., Berg, T., Malfertheiner, P., Klümpen, H. J., Sengel, C., Basu, B., Valle, J. W., Benckert, J., Gasbarrini, A., Palmer, D., Seidensticker, R., Wildgruber, M., Sangro, B., Pech, M., Ricke, J., & Seidensticker, M. (2021). Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial. Journal of cancer research and clinical oncology, . https://doi.org/10.1007/s00432-021-03627-1
Öcal, Osman, et al. "Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial." Journal of cancer research and clinical oncology vol. (2021). doi: https://doi.org/10.1007/s00432-021-03627-1
Öcal O, Schütte K, Kupčinskas J, Morkunas E, Jurkeviciute G, de Toni EN, Ben Khaled N, Berg T, Malfertheiner P, Klümpen HJ, Sengel C, Basu B, Valle JW, Benckert J, Gasbarrini A, Palmer D, Seidensticker R, Wildgruber M, Sangro B, Pech M, Ricke J, Seidensticker M. Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial. J Cancer Res Clin Oncol. 2021 Apr 14; doi: 10.1007/s00432-021-03627-1. Epub 2021 Apr 14. PMID: 33855585.
Copy Download .nbib Format: NLM
Current state of multidisciplinary treatment in cholangiocarcinoma.

Digestive diseases (Basel, Switzerland)

Ben Khaled N, Jacob S, Rössler D, Bösch F, De Toni EN, Werner J, Ricke J, Mayerle J, Seidensticker M, Schulz C, Fabritius MP.
PMID: 34695826
Dig Dis. 2021 Oct 25; doi: 10.1159/000520346. Epub 2021 Oct 25.

BACKGROUND: Cholangiocarcinoma (CCA) is a highly aggressive malignancy, and its incidence seems to be increasing over the last years. Given the high rate of irresectability at the time of initial diagnosis, new treatment approaches are important to achieve better...

Cite
Ben Khaled N, Jacob S, Rössler D, et al. Current state of multidisciplinary treatment in cholangiocarcinoma. Dig Dis. 2021;doi: 10.1159/000520346.
Ben Khaled, N., Jacob, S., Rössler, D., Bösch, F., De Toni, E. N., Werner, J., Ricke, J., Mayerle, J., Seidensticker, M., Schulz, C., & Fabritius, M. P. (2021). Current state of multidisciplinary treatment in cholangiocarcinoma. Digestive diseases (Basel, Switzerland), . https://doi.org/10.1159/000520346
Ben Khaled, Najib, et al. "Current state of multidisciplinary treatment in cholangiocarcinoma." Digestive diseases (Basel, Switzerland) vol. (2021). doi: https://doi.org/10.1159/000520346
Ben Khaled N, Jacob S, Rössler D, Bösch F, De Toni EN, Werner J, Ricke J, Mayerle J, Seidensticker M, Schulz C, Fabritius MP. Current state of multidisciplinary treatment in cholangiocarcinoma. Dig Dis. 2021 Oct 25; doi: 10.1159/000520346. Epub 2021 Oct 25. PMID: 34695826.
Copy Download .nbib Format: NLM
HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience.

Frontiers in oncology

Walter F, Fuchs F, Gerum S, Rottler MC, Erdelkamp R, Neumann J, Nierer L, Guba M, De Toni EN, Seidensticker M, Ricke J, Belka C, Corradini S.
PMID: 34513694
Front Oncol. 2021 Aug 26;11:717792. doi: 10.3389/fonc.2021.717792. eCollection 2021.

BACKGROUND: In the treatment of patients with HCC awaiting liver transplantation (LT), local ablative treatments (LAT) are available either for downstaging or as bridging treatment. We present our clinical experience with both available radiation-based techniques, brachytherapy (BT), and stereotactic...

Cite
Walter F, Fuchs F, Gerum S, et al. HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience. Front Oncol. 2021;11:717792doi: 10.3389/fonc.2021.717792.
Walter, F., Fuchs, F., Gerum, S., Rottler, M. C., Erdelkamp, R., Neumann, J., Nierer, L., Guba, M., De Toni, E. N., Seidensticker, M., Ricke, J., Belka, C., & Corradini, S. (2021). HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience. Frontiers in oncology, 11717792. https://doi.org/10.3389/fonc.2021.717792
Walter, Franziska, et al. "HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience." Frontiers in oncology vol. 11 (2021): 717792. doi: https://doi.org/10.3389/fonc.2021.717792
Walter F, Fuchs F, Gerum S, Rottler MC, Erdelkamp R, Neumann J, Nierer L, Guba M, De Toni EN, Seidensticker M, Ricke J, Belka C, Corradini S. HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience. Front Oncol. 2021 Aug 26;11:717792. doi: 10.3389/fonc.2021.717792. eCollection 2021. PMID: 34513694; PMCID: PMC8426600.
Copy Download .nbib Format: NLM
Showing 97 to 99 of 99 entries